These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9455569)

  • 1. Rhabdomyolysis in human immunodeficiency virus--positive patients taking trimethoprim-sulfamethoxazole.
    Singer SJ; Racoosin JA; Viraraghavan R
    Clin Infect Dis; 1998 Jan; 26(1):233-4. PubMed ID: 9455569
    [No Abstract]   [Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole-induced rhabdomyolysis in an allogeneic stem cell transplant patient.
    Kiel PJ; Dickmeyer N; Schwartz JE
    Transpl Infect Dis; 2010 Oct; 12(5):451-4. PubMed ID: 20561303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole associated rhabdomyolysis in a patient with AIDS: case report and review of the literature.
    Walker S; Norwood J; Thornton C; Schaberg D
    Am J Med Sci; 2006 Jun; 331(6):339-41. PubMed ID: 16775445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Marsh BJ
    Clin Infect Dis; 1997 Sep; 25(3):754-6. PubMed ID: 9314486
    [No Abstract]   [Full Text] [Related]  

  • 5. Restarting trimethoprim-sulfamethoxazole after a hypersensitivity reaction in patients infected with the human immunodeficiency virus.
    Everson-Mays RE; Weidle PJ
    Am J Health Syst Pharm; 1997 Jul; 54(13):1545-50. PubMed ID: 9217946
    [No Abstract]   [Full Text] [Related]  

  • 6. Case reports: trimethoprim-sulfamethoxazole-induced meningitis in patients with HIV infection.
    Jurado R; Carpenter SL; Rimland D
    Am J Med Sci; 1996 Jul; 312(1):27-9. PubMed ID: 8686726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal hepatic lesions on magnetic resonance imaging induced by trimethoprim/sulfamethoxazole in HIV infection.
    Takahashi T; Taguchi H; Nakamura T; Yoshikawa K; Iwamoto A
    Ann Pharmacother; 1999 Sep; 33(9):1007-8. PubMed ID: 10492507
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection.
    Rieder MJ; King SM; Read S
    Pediatr Infect Dis J; 1997 Nov; 16(11):1028-31. PubMed ID: 9384334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection.
    Anders HJ; Bogner JR; Goebel FD
    Eur J Med Res; 1997 May; 2(5):198-200. PubMed ID: 9153343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyolysis and the acquired immunodeficiency syndrome.
    Beversdorf D; Mattison HR
    Neurology; 1996 May; 46(5):1498. PubMed ID: 8628523
    [No Abstract]   [Full Text] [Related]  

  • 11. Vanishing bile duct syndrome arising in a patient with HIV infection sequentially treated with trimethoprim/sulfamethoxazole and dapsone.
    Kathi PR; Tama M; Ehrinpreis M; Mutchnick M; Westerhoff M; Mowers J; Fontana RJ
    Clin J Gastroenterol; 2020 Apr; 13(2):276-280. PubMed ID: 31317370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin testing in AIDS patients with cutaneous trimethoprim-sulfamethoxazole hypersensitivity.
    Simonart T; Parent D; Heenen M; Farber CM; Van Vooren JP
    Clin Exp Dermatol; 1998 Jan; 23(1):47. PubMed ID: 9667114
    [No Abstract]   [Full Text] [Related]  

  • 13. Glutathione in hypersensitivity to trimethoprim/sulfamethoxazole in patients with HIV infection.
    Rose EW; McCloskey WW
    Ann Pharmacother; 1998 Mar; 32(3):381-3. PubMed ID: 9533069
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.
    Smith CL; Brown I; Torraca BM
    Clin Infect Dis; 1997 Dec; 25(6):1477-8. PubMed ID: 9431404
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute psychosis related to use of trimethoprim/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study.
    Lee KY; Huang CH; Tang HJ; Yang CJ; Ko WC; Chen YH; Lee YC; Hung CC
    J Antimicrob Chemother; 2012 Nov; 67(11):2749-54. PubMed ID: 22821870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trial.
    Pellegrino D; Gryschek R; de Oliveira ACP; Marcusso R; Correia A; Vidal JE
    Int J STD AIDS; 2019 Oct; 30(12):1156-1162. PubMed ID: 31558125
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse reactions to trimethoprim-sulfamethoxazole.
    Lee BL
    Clin Rev Allergy Immunol; 1996-1997 Winter; 14(4):451-5. PubMed ID: 9040971
    [No Abstract]   [Full Text] [Related]  

  • 18. Trimethoprim-sulfamethoxazole-induced sepsis-like syndrome in a patient with AIDS.
    O'Kane EB; Schneeweiss R
    J Am Board Fam Pract; 1996; 9(6):448-50. PubMed ID: 8923404
    [No Abstract]   [Full Text] [Related]  

  • 19. Trimethoprim-sulfamethoxazole induced rhabdomyolysis.
    Ainapurapu B; Kanakadandi UB
    Am J Ther; 2014; 21(3):e78-9. PubMed ID: 23689093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperkalemia under treatment with high-dose trimethoprim-sulfamethoxazole].
    Fouché R; Bernardin G; Roger PM; Corcelle P; Simler JM; Mattei M
    Presse Med; 1996 Dec; 25(40):2044. PubMed ID: 9082385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.